Kommersant: the Russian company Valenta Pharm produces the drug innoviron against COVID-19 innovation, the developer of the drug was Valenta Pharm, Kommersant reports.
Experts conducted the second phase of drug testing back in June. At the end of October this year, documents were sent to register the development.
Valenta Pharm had previously attempted to create a drug against coronavirus. According to Kommersant's information, Ingavirin was tested, but the results were not so successful.
Last week, Britain announced the registration of the world's first COVID-19 drug – molnupiravir from Merck. In addition, Pfizer announced its own development – poxlavir. These drugs act on coronavirus enzymes, blocking them.
Earlier, virologist Sergei Netesov said that acute respiratory viral infections and COVID-19 do not differ between symptoms, the disease can only be clarified through testing.